Main news


Heart failure: Flu vaccine could save lives People with heart failure are more susceptible to flu complications than other people. However, a new study has revealed that flu vaccinations may have a significant impact on lifespan.



CMS Reminds Physicians of Meaningful Use Hardship Exception Deadline Ken Terry The Centers for Medicare & Medicaid Services (CMS) is reminding physicians who did not attest to meaningful use (MU) of electronic health records (EHR) in 2013 that they have until July 1 of this year to apply for a hardship exception so they can avoid a financial penalty in 2015.



Flu Vaccine More Effective Than Last Year’s, CDC Says Robert Lowes The seasonal influenza vaccine for 2013-2014 so far is outperforming its predecessor from last season in protecting Americans from the flu bug, the Centers for Disease Control and Prevention (CDC) announced today



Lack of Vitamin D Linked to CVD Biomarkers, Inflammation Marlene Busko COLERAINE, UK — Older, healthy individuals who were deficient in 25-hydroxy vitamin D (vitamin D) tended to have higher levels of biomarkers linked with CVD and inflammatory conditions such as multiple sclerosis and rheumatoid arthritis, in an observational study.



SSRI May Negatively Affect Male Fertility Fran Lowry The selective serotonin reuptake inhibitor (SSRI) sertraline (Zoloft, Pfizer Inc) may have a negative impact on some semen parameters, a finding that may have implications for male fertility, new research suggests.



Autism Rates Jump 30%, CDC Reports Megan Brooks More children in the United States have an autism spectrum disorder (ASD) than previously thought, the US Centers for Disease Control and Prevention (CDC) reports today.



FDA Panel Recommends 2 New Anti-MRSA Agents Larry Hand The Anti-Infective Drugs Advisory Committee of the US Food and Drug Administration (FDA) has voted unanimously to recommend approval of 2 new antibacterial agents for the treatment of skin and skin structure infections caused by gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).


Newspaper “Cardiology today”
Newspaper “Cardiology today” Quarterly scientific newspaper "Cardiology Today" is published in conjunction with the Publishing House "ABC-press".


Informational bulletin “Cardioprogress”
Informational bulletin “Cardioprogress” Bulletin is published four times a year in both Russian and English (special issues) languages.



ED Drugs Linked to Increased Melanoma Risk Larry Hand Use of sildenafil (Viagra, Pfizer) is associated with an increased risk for melanoma, according to an article published online April 7 in JAMA Internal Medicine.


The Scientific Committee begins accepting abstracts and applications for the scientific program of the XI International Forum of Cardiology and Internal Medicine
The Scientific Committee begins accepting abstracts and applications for the scientific program of the XI International Forum of Cardiology and Internal Medicine Dear Colleagues! We invite you to take part in XI International Forum of Cardiology and Internal Medicine. Forum will take place on 22-24 March 2022 in Moscow (online).


Analysis of the activities of the
Analysis of the activities of the "Cardioprogress" foundation: results of 2021 Dear colleagues! In 2021, a number of significant events took place in cardiology. Due to the continuation of restrictive measures, most scientific events were organized online. This required adaptation and the acquisition of new skills. However, all planned events took place.


Editorial Activity

cardiology book

FDA Clears Architect Stat High-Sensitivity Troponin Test for MI
FDA Clears Architect Stat High-Sensitivity Troponin Test for MI The US Food and Drug Administration (FDA) has approved the Architect Stat (Abbott Laboratories) high-sensitivity troponin-I assay, which can detect myocardial infarction (MI) faster and more accurately than other troponin tests, according to the company.


World Heart Day 2019
World Heart Day 2019 This year on World Heart Day, as part of our mission to ensure heart health equity for all, we want to create a global community of Heart Heroes … people from all walks of life who are acting now to live longer, better, heart-healthy lives by making a promise: for MY HEART, for YOUR HEART, for ALL OUR HEARTS.


ESC 2019: Wrap up in Russian - Live and interactive programme
ESC 2019: Wrap up in Russian - Live and interactive programme In collaboration with the Russian Society of Cardiology, this programme is designed to present a selection of scientific highlights from ESC Congress and discuss clinical practice implications with experts.


ESC Congress 2019                      together with World Congress of Cardiology
ESC Congress 2019 together with World Congress of Cardiology ESC Congress 2019 together with World Congress of Cardiology Saturday 31 August - Wednesday 4 September 2019 Paris - France


Announcement of the European Congress of Cardiology
Announcement of the European Congress of Cardiology From August 31 to September 4, 2019, he Congress of the European Society of Cardiology in conjunction with the World Congress of Cardiology - will be held in Paris (France).


Trial Evaluating Sacubitril/Valsartan for HFpEF Misses Primary End Point
Trial Evaluating Sacubitril/Valsartan for HFpEF Misses Primary End Point Full detailed data from PARAGON-HF will be presented at the ESC Congress 2019 in September. Novartis announced topline results from the phase 3 PARAGON-HF study evaluating the safety and efficacy of sacubitril/valsartan (Entresto) in heart failure patients with preserved ejection fraction (HFpEF).


ESC Congress 2019                      together with World Congress of Cardiology
ESC Congress 2019 together with World Congress of Cardiology Full detailed data from PARAGON-HF will be presented at the ESC Congress 2019 in September. Novartis announced topline results from the phase 3 PARAGON-HF study evaluating the safety and efficacy of sacubitril/valsartan (Entresto) in heart failure patients with preserved ejection fraction (HFpEF).


Certain Social, Behavioral Factors Associated With Diabetes and Hypertension Onset
Certain Social, Behavioral Factors Associated With Diabetes and Hypertension Onset Education and exercise may determine early start of diabetes and hypertension. Select behavioral and social risk factors were correlated with early onset of hypertension and diabetes, a prospective cohort study found. At 3.5 years of follow-up, among the patients without diabetes at baseline, 4% developed diabetes, while 6.4% of the cohort without baseline hypertension developed hypertension, reported Matthew Pantell, MD, MS, of the University of California, San Francisco, and colleagues.